Remedent, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Sternberg Stuart, was filed 03 Dec 2015.
Remedent, Inc.: what insiders have been doing
Remedent, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Remedent, Inc. has had no insider filing for more than a year; the last one goes back to 3 December 2015.
Since 2006, the database holds 45 purchases and 20 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Since the insiders bought
- +5.3%Entry US$0.19 · Close at T+365 US$0.20
- -60.9%Entry US$0.69 · Close at T+365 US$0.27
- -25.0%Entry US$0.52 · Close at T+365 US$0.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 399,819 shares@ US$0.15Common Stock, no par valueSEC:0001144204-15-069124:0Canonical exit: 1 Mar 2016 (T+90)
- 399,819 shares@ US$0.40Common Stock, no par valueSEC:0001144204-15-068969:0Canonical exit: 1 Mar 2016 (T+90)
- 2,848,408 shares@ US$0.0851Common StockSEC:0001044321-13-000102:0
- 225,000 shares@ US$0.1003Common StockSEC:0001044321-13-000101:0
- 165,000 shares@ US$0.10Common StockSEC:0001044321-13-000101:1
- 500 shares@ US$0.11Common StockSEC:0001044321-13-000101:2
- 713,025 shares@ US$0.0946Common StockSEC:0001044321-13-000100:0
- 45,000 shares@ US$0.12Common StockSEC:0001044321-12-000194:0
- 200,000 shares@ US$0.12Common StockSEC:0001044321-12-000194:1
- 60,000 shares@ US$0.1329Common StockSEC:0001044321-12-000191:0
- 5,000 shares@ US$0.15Common StockSEC:0001044321-12-000191:1
- 84,000 shares@ US$0.1232Common StockSEC:0001044321-12-000191:2
- 175,000 shares@ US$0.25Common StockSEC:0001044321-12-000134:0
- 10,000 shares@ US$0.395Common StockSEC:0001044321-12-000056:0
- 11,000 shares@ US$0.40Common StockSEC:0001044321-12-000056:1
- 5,000 shares@ US$0.33Common StockSEC:0001044321-12-000052:0
- 4,000 shares@ US$0.3675Common StockSEC:0001044321-12-000052:1
- 30,000 shares@ US$0.28Common StockSEC:0001044321-12-000050:0
- 400 shares@ US$0.25Common StockSEC:0001044321-11-000184:0
- 500 shares@ US$0.65Common StockSEC:0001044321-11-000030:0Canonical exit: 1 May 2011 (T+90)
- 25,000 shares@ US$0.7481Common StockSEC:0001044321-11-000029:0Canonical exit: 27 Apr 2011 (T+90)
- 7,500 shares@ US$0.65Common StockSEC:0001044321-11-000027:0Canonical exit: 21 Apr 2011 (T+90)
- 1,899 shares@ US$0.65Common StockSEC:0001044321-11-000027:1Canonical exit: 24 Apr 2011 (T+90)
- 29,000 shares@ US$0.5247Common StockSEC:0001044321-11-000025:0Canonical exit: 19 Apr 2011 (T+90)
- 22,000 shares@ US$0.6352Common StockSEC:0001044321-11-000025:1Canonical exit: 20 Apr 2011 (T+90)
25 of 73 declarations
About Remedent, Inc.
Remedent, Inc. is a company listed on the XNAS market. It specializes in the development and marketing of innovative dental products.
